For more than 75 years, Kerry has provided integrated solutions for the world’s leading biotechnology customers. We are a global leader that deliver innovative solutions to assist in many stages of the vaccine development including enhance cell growth and antigen generation, reduce or eliminate serum, and vaccine formulation.
Every day we expand our capabilities to meet the changing needs of the biotech market. Kerry’s products have evolved with market trends in cell culture over the last fifty years to fulfil our customers’ requirement and has grown to encompass modern plant based hydrolysates, yeast extracts, recombinant proteins, cell line tailored supplement systems, and chemically defined medium. We have the vast global resources and technical platform to deliver consistent, high-quality products backed by unparalleled service, technical support, and formulation customization capabilities.